A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.

NCT00442793 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

265

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Epoetin beta
DRUG: methoxy polyethylene glycol-epoetin beta [Mircera]

Sponsor

Hoffmann-La Roche